Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group (Q34512590)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group |
scientific article |
Statements
1 reference
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group (English)
1 reference
S L Neuhausen
1 reference
M Robson
1 reference
S A Narod
1 reference
J S Brunet
1 reference
P Ghadirian
1 reference
C Lerman
1 reference
B Pasini
1 reference
P de los Rios
1 reference
B Weber
1 reference
H Lynch
1 reference
Hereditary Breast Cancer Clinical Study Group
1 reference
1 December 2000
1 reference
1 reference
356
1 reference
9245
1 reference
1876-1881
1 reference
Identifiers
1 reference
1 reference